A proposal from the Liver Forum for the management of comorbidities in nonalcoholic steatohepatitis therapeutic trials
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A proposal from the Liver Forum for the management of comorbidities in nonalcoholic steatohepatitis therapeutic trials
Authors
Keywords
-
Journal
JOURNAL OF HEPATOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-03-29
DOI
10.1016/j.jhep.2023.03.014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease
- (2022) Katharina Staufer et al. JOURNAL OF HEPATOLOGY
- The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/Obesity
- (2022) Laura E Dichtel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2022) Melanie J. Davies et al. DIABETOLOGIA
- NAFLD as a metabolic disease in humans: A literature review
- (2021) Bertrand Cariou et al. DIABETES OBESITY & METABOLISM
- Anti-diabetic drugs and NASH: from current options to promising perspectives
- (2021) Sarra Smati et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Advancing the global public health agenda for NAFLD: a consensus statement
- (2021) Jeffrey V. Lazarus et al. Nature Reviews Gastroenterology & Hepatology
- Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations from the Multi-stakeholder Liver Forum
- (2020) Mazen Noureddin et al. GASTROENTEROLOGY
- Standardization of Diet and Exercise in Clinical Trials of NAFLD-NASH: Recommendations from the Liver Forum
- (2020) Oliver Glass et al. JOURNAL OF HEPATOLOGY
- Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality
- (2020) Donghee Kim et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis
- (2020) Guillaume Lassailly et al. GASTROENTEROLOGY
- Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
- (2020) Stephen A. Harrison et al. GASTROENTEROLOGY
- Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Association
- (2020) Janani Rangaswami et al. CIRCULATION
- HEP‐20‐1087: Measuring the Alcohol in Alcohol‐related Liver Disease: Choices and Challenges for Clinical Research
- (2020) Jessica Mellinger et al. HEPATOLOGY
- Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
- (2020) Sven Francque et al. Nature Reviews Gastroenterology & Hepatology
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- The loss-of-function PCSK9Q152H variant increases ER chaperones GRP78 and GRP94 and protects against liver injury
- (2020) Paul F. Lebeau et al. JOURNAL OF CLINICAL INVESTIGATION
- Genetic Inhibition of PCSK9 and Liver Function
- (2020) Antoine Rimbert et al. JAMA Cardiology
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- A note on the draft International Council for Harmonisation guidance on estimands and sensitivity analysis
- (2019) Devan V Mehrotra Clinical Trials
- Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations from the Liver Forum
- (2019) Amanda Cheung et al. HEPATOLOGY
- Diagnosis and Treatment of Alcohol‐Related Liver Diseases: 2019 Practice Guidance from the American Association for the Study of Liver Diseases
- (2019) David W. Crabb et al. HEPATOLOGY
- Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial
- (2019) Richard Pratley et al. LANCET
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease
- (2019) Miriam B. Vos et al. GASTROENTEROLOGY
- Low Testosterone Is Associated With Nonalcoholic Steatohepatitis (NASH) and Severity of NASH Fibrosis in Men With NAFLD
- (2019) Monika Sarkar et al. Clinical Gastroenterology and Hepatology
- 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETOLOGIA
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Rates and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis
- (2018) Ma Ai Thanda Han et al. Clinical Gastroenterology and Hepatology
- Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
- (2018) Mohammad Shafi Kuchay et al. DIABETES CARE
- Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
- (2018) Bo Ahrén et al. DIABETES OBESITY & METABOLISM
- Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
- (2018) Mohammad Shadab Siddiqui et al. HEPATOLOGY
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- The PEth Blood Test in the Security Environment: What it is; Why it is Important; and Interpretative Guidelines
- (2018) William Ulwelling et al. JOURNAL OF FORENSIC SCIENCES
- Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study
- (2018) Gyuri Kim et al. JOURNAL OF HEPATOLOGY
- Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes
- (2018) Ming-Wai Yeung et al. JOURNAL OF HEPATOLOGY
- Women and alcoholic liver disease — warning of a silent danger
- (2018) Gyongyi Szabo Nature Reviews Gastroenterology & Hepatology
- Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: the NHANES III Linked Mortality Study
- (2018) Donghao Zhou et al. Scientific Reports
- Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels
- (2018) Mattias Brunström et al. JAMA Internal Medicine
- Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® trial
- (2018) Naveed Sattar et al. DIABETOLOGIA
- 2018 ESC/ESH Guidelines for the management of arterial hypertension
- (2018) Bryan Williams et al. EUROPEAN HEART JOURNAL
- Metabolic effects of reduced growth hormone action in fatty liver disease
- (2018) Kerstin Rufinatscha et al. Hepatology International
- Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease
- (2018) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States
- (2018) Donghee Kim et al. Clinical Gastroenterology and Hepatology
- 6. Glycemic Targets: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Liraglutide, sitagliptin and insulin glargine added to metformin: the effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and NAFLD
- (2018) Jinhua Yan et al. HEPATOLOGY
- Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis
- (2018) Mary E. Rinella et al. JOURNAL OF HEPATOLOGY
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
- (2018) Scott M. Grundy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum
- (2017) Yuval A. Patel et al. GASTROENTEROLOGY
- Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
- (2017) Leon A Adams et al. GUT
- Ezetimibe for the treatment of non-alcoholic fatty liver disease: A meta-analysis
- (2017) Yukiomi Nakade et al. HEPATOLOGY RESEARCH
- Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
- (2017) Mohammad H. Forouzanfar et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Why Has a Run-In Period Been a Design Element in Most Landmark Clinical Trials? Analysis of the Critical Role of Run-In Periods in Drug Development
- (2017) Milton Packer JOURNAL OF CARDIAC FAILURE
- Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features
- (2017) Everton Cazzo et al. OBESITY SURGERY
- A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis
- (2017) Stuart McPherson et al. PLoS One
- Improved detection of alcohol consumption using the novel marker phosphatidylethanol in the transplant setting: results of a prospective study
- (2017) Hilke Andresen-Streichert et al. TRANSPLANT INTERNATIONAL
- Androgen Deficiency Exacerbates High-Fat Diet-Induced Metabolic Alterations in Male Mice
- (2016) Vanessa Dubois et al. ENDOCRINOLOGY
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Fatty liver is an independent predictor of early carotid atherosclerosis
- (2016) Raluca Pais et al. JOURNAL OF HEPATOLOGY
- Type 2 diabetes and risk of hospital admission or death for chronic liver diseases
- (2016) Sarah H. Wild et al. JOURNAL OF HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
- (2016) Jeffrey Cui et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
- (2016) Dena Ettehad et al. LANCET
- Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease
- (2016) Zhenghui G. Jiang et al. LIVER INTERNATIONAL
- Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
- (2016) Serena Pelusi et al. PLoS One
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
- (2015) Guillaume Lassailly et al. GASTROENTEROLOGY
- Anti-angiogenic effect of metformin in human liver carcinogenesis related to metabolic syndrome
- (2015) François Cauchy et al. GUT
- Ezetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)
- (2015) Rohit Loomba et al. HEPATOLOGY
- Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study
- (2015) Vincent Wai-Sun Wong et al. HEPATOLOGY
- Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
- (2015) Stuart McPherson et al. JOURNAL OF HEPATOLOGY
- Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetes
- (2015) Fernando Bril et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years
- (2015) Ulla Ludwig et al. BMC Endocrine Disorders
- Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension
- (2014) Ki-Chul Sung et al. JOURNAL OF HEPATOLOGY
- Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia
- (2014) Mathilde Di Filippo et al. JOURNAL OF HEPATOLOGY
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2014) Giovanni Musso et al. PLOS MEDICINE
- Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
- (2013) Siddharth Singh et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population
- (2013) Han Ma et al. BMC GASTROENTEROLOGY
- Association Between High-Normal Levels of Alanine Aminotransferase and Risk Factors for Atherogenesis
- (2013) M. Shadab Siddiqui et al. GASTROENTEROLOGY
- Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome
- (2013) Derrick M. Van Rooyen et al. JOURNAL OF HEPATOLOGY
- A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
- (2013) Raluca Pais et al. JOURNAL OF HEPATOLOGY
- Testosterone and insulin resistance in the metabolic syndrome and T2DM in men
- (2013) Preethi M. Rao et al. Nature Reviews Endocrinology
- Association of run-in periods with weight loss in obesity randomized controlled trials
- (2013) O. Affuso et al. Obesity Reviews
- Non-Alcoholic Fatty Liver Disease Is Associated with an Increased Incidence of Atrial Fibrillation in Patients with Type 2 Diabetes
- (2013) Giovanni Targher et al. PLoS One
- The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
- (2013) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience
- (2012) D. E. Bonds et al. DIABETOLOGIA
- Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
- (2012) Siddharth Singh et al. GASTROENTEROLOGY
- Non-alcoholic fatty liver disease across the spectrum of hypothyroidism
- (2012) Goh Eun Chung et al. JOURNAL OF HEPATOLOGY
- Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study
- (2011) R.-D. Ting et al. DIABETES CARE
- Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial
- (2011) Dawn M. Torres et al. HEPATOLOGY
- Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese
- (2011) Judith Aron-Wisnewsky et al. JOURNAL OF HEPATOLOGY
- Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients
- (2011) Edith Koehler et al. LIVER INTERNATIONAL
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Histological Course of Nonalcoholic Fatty Liver Disease in Japanese Patients: Tight glycemic control, rather than weight reduction, ameliorates liver fibrosis
- (2009) E. Hamaguchi et al. DIABETES CARE
- Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
- (2009) Juan G. Abraldes et al. GASTROENTEROLOGY
- Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
- (2009) Hashem B. El–Serag et al. GASTROENTEROLOGY
- Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis
- (2009) Koji Fujita et al. HEPATOLOGY
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease
- (2008) Mattias Ekstedt et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started